Cleared Traditional

K151576 - Neon EEG

K151576 is an FDA 510(k) clearance for Neon EEG, manufactured by Incereb, Ltd.. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 110-day FDA review.

K151576 · Incereb, Ltd. · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2015
Decision
110d
Days
Class 2
Risk

K151576 is an FDA 510(k) clearance for the Neon EEG. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Incereb, Ltd. (Dublin, IE). The FDA issued a Cleared decision on September 29, 2015 after a review of 110 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K151576

510(k) Number K151576 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 11, 2015
Decision Date September 29, 2015
Days to Decision 110 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
39d faster than avg
Panel avg: 149d · This submission: 110d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 358
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K151576.
Mailuokang Self-adhesive Electrode
K152815 · Shenzhen Mailuokang Technology Co., Ltd. · Mar 2016
Ennova Self-adhesive Electrode
K152648 · Suzhou Ennova Electronics Technology Co.,Ltd · Feb 2016
Dr-Ho's Foot Pad Electrode
K151693 · Drtv Asia, Ltd. · Oct 2015
Zekang Self-adhesive Electrode
K150971 · Jiangsu Zekang Medical Technology Co., Ltd. · Aug 2015
Philips Self-Adhesive Electrodes
K151033 · Philips Consumer Lifestyle · Jul 2015
DISPOSABLE PRE-GELLED SURFACE ELECTRODE
K142159 · Rochester Electro Medical, Inc. · Jun 2015